Insights provides context and perspective about key pharmacy trends and issues

Icon of documents with a checkmark symbol
Public Policy
A New Agenda for the FDA
A focus on prioritizing generic review and fostering competition could help in the battle against sky-rocketing prescription drug costs. More
Commentary
Icon of court building
Public Policy
Advocating for Better Drug Pricing Policy at HHS
Lowering out-of-pocket consumer costs, ending manipulation and abuse of FDA regulations, and fostering greater competition can help lower high prescription drug costs. More
Commentary
Icon of two intersecting speech bubbles
Public Policy
House Votes to Dismantle the ACA – Now What?
House Republicans passed their version of a new health care law, but the Senate version is likely to be very different. A replacement for ACA may take some time. More
Commentary
Icon of two intersecting speech bubbles
Public Policy
ACA, After The Elections
With the Republican Party maintaining control of both the House of Representatives and the Senate and President-elect Donald Trump preparing to assume office, their long-sought goal of... More
Commentary
Icon of bank with dollar sign
Public Policy
Cadillac Tax
The high-cost health plan tax – excise or "Cadillac" tax as it is commonly known – is one of the yet-to-be implemented portions of the Affordable Care Act (ACA). The purpose of... More
Feature
Icon of pill bottle with dollar sign
Public Policy
Advocating for Better Public Policy on Pharmacy Benefits
Plan sponsors who provide prescription drug coverage to their plan members count on pharmacy benefit managers (PBMs) to help ensure appropriate utilization, lower costs and improved health... More
Feature
  •